Glioblastoma is a very aggressive astrocytic tumor and most patients have 1-year survival time after diagnosis. A promising therapeutic strategy is the local delivery of the herpes simplex virus thymidine kinase gene in the tumor bed followed by ganciclovir treatment. The presence of functional gap junctions is highly relevant for the success of suicide gene therapy. Connexins are expressed in practically all tissues and form gap junctions that allow intercellular communication. Connexin 43 (Cx43) is the major connexin member being expressed in astrocytes but its status in glioblastoma is not well defined. We have investigated by immunofluorescence the presence of Cx43 in 74 human glioblastoma samples; its expression was detected in 77% of the samples analyzed. We report here that glioblastoma is a heterogenous disease as regards Cx43 expression with presentations, in which Cx43 expression is unaltered, reduced or totally lost. A predominant Cx43 cytoplasmic localization was observed in four out of eight primary glioblastoma cultures that we have established. This aberrant localization reduced gap junctionnal intercellular communication by 50 to 75% as compared with primary cell cultures displaying gap junctional plaques. However, the bystander effect evaluated after lentiviral delivery of the herpes simplex virus thymidine kinase gene and ganciclovir treatment was detected in all Cx43-positive primary cell cultures, and it was independant of the Cx43 localization. These findings may have important clinical implications for the design of anticancer cytotoxic therapies that rely on the gap junction-mediated bystander effect for their success.
Introduction
Gap junctions form channels at the cell surface that allow passive diffusion of small hydrophylic molecules (p1 kD) between cells that can be ions, short peptides, nucleotides and other metabolites. Gap junctions are composed of six connexin molecules that oligomerize to form a hemichannel (connexon) at the cell surface that will dock with a connexon expressed by an adjacent cell. Gap-junctional intercellular communication is involved in several physiological processes like the contraction of the heart and uterus, electrical coupling of cells, embryonic development, and cell growth and differentiation. 1 Connexins (Cx followed by their molecular weight) belong to a family comprising more than 19 members in mice and 20 members in humans. 2 They are differentially expressed with some members being specific to certain tissues, and others like Cx43 being more ubiquitously expressed (nervous tissue, heart and muscles). 3 Connexins have been involved in cardiovascular diseases and in several genetic diseases: mutations in Cx26, Cx30 and Cx31 are involved in non-syndromic deafness, mutations in Cx43 and Cx32 have been linked to oculodentodigital dysplasia and Charcot-Marie tooth syndrome, respectively. 1 Glioma cells expressing Cx43, the connexin subtype that is expressed in astrocytes, form gap-junctional intercellular communication with normal astrocytes promoting tumor cell infiltration into the surrounding brain tissue in rodents and in organotypic brain slice cultures. [4] [5] [6] In line with these observations, glioblastoma, the highest glioma grade, is characterized by its intraparenchymal dissemination that leads to recurrence despite aggressive treatments. A similar role in tumor dissemination was suggested for Cx26 in lung squamous cell carcinoma, in breast cancer and in papillary and follicular thyroid cancers. [7] [8] [9] In contrast, a few other studies suggested that the level of Cx43 expression inversely correlates with the glioma grade, with very low levels or complete absence of Cx43 in glioblastomas.
These studies suggest that Cx43 downregulation is involved in the progression of gliomas and do not support the infiltrative role of Cx43 in glioblastomas. 15 Glioblastoma patients have a mean survival time of a year despite aggressive therapies like surgery, radiotherapy and chemotherapy, but new approaches are actively being developed to improve the outcome of this disease. 16 One such strategy is the local delivery of the herpes simplex virus thymidine kinase (TK) gene in the tumor bed after resection. After a promising phase 1 clinical trial, 17 this strategy is now under investigation in a phase 3 randomized multi-centre study. TKexpressing tumor cells will then become sensitized to ganciclovir (GCV) treatment. Indeed, TK phosphorylates the nucleoside analog GCV that is subsequently converted into phosphorylated toxic compounds. 18 Cx43 expression and functional gap-junctional intercellular communication are responsible for the potent antitumoral effect observed with this approach, as phosphorylated GCV can diffuse through gap junctions into neighboring TK negative cells. [18] [19] [20] [21] This bystander effect (BE) compensates in part for the lack of efficient and homogeneous delivery of the transgene in tumor cells.
To this date, the downregulation of Cx43 was reported only in a few studies that examined small numbers of clinical samples. 4, 10, 12, 13 Given the importance that gap junctions have in the TK/GCV suicide gene therapy strategy, it was imperative to define the status of connexin expression in glioblastoma. We report here the results obtained from the analysis of Cx43 expression in 74 surgical specimens of glioblastomas. In addition, the localization and functionality of gap junctions measured by a specific dye-transfer assay and the GCV-mediated BE were analyzed in eight primary glioblastoma cell cultures.
Materials and methods
Tissue specimens and primary glioblastoma cell cultures This clinical study was approved by the ethical committee of Hoˆpital de l'Enfant-Je´sus. After obtaining informed consent, frozen tissue sections of 74 patients with diagnosed glioblastoma were obtained from the Neuropathology Department at Hoˆpital de l'Enfant-Je´sus between 2004 and 2006. The median age was 60.3 years, and 62.2% of patients had undergone debulking surgery. Radiotherapy plus concomitant and adjuvant temozolomide treatment was given to 79.7% of patients. The histological characteristics of the slides were compatible with the World Health Organization grade IV description as most of the samples displayed necrosis (88.9%) and medium to high proliferation rate. For MIB-1 staining, distinct nuclear staining of the tumor cell was recorded as positive. The MIB-1 labeling index was defined as the percentage of immunoreactive tumor cells in the evaluated area. Vascular components and hematogenous cells were excluded. The evaluated areas also excluded necrotic, degenerated and poorly preserved areas. More than 80% of the slides were moderate to high GFAP positives (Table 1 ). In addition, three non-neoplastic brain tissue samples obtained after surgical operations performed to treat epilepsy were used as positive controls for Cx43 immunostaining. The slides were stored at À80 1C until needed.
Nine freshly resected glioblastoma specimens were collected during surgical operations in the Department of Neurosurgery at Hoˆpital de l'Enfant-Je´sus. Immediately after surgery, tissues were placed in an ice-cold dissection medium; Ham's F10 medium (Sigma, St Louis, MO) with 20 mM HEPES and penicillin/streptomycin antibiotics (Invitrogen, Burlington, Ontario, Canada). Within 1 h post-surgery, tissues were mecanically dissected in 1 mm fragments with scissors, cleaned of blood cells and incubated for 4 h at 37 1C with gentle agitation in Opti-MEM medium (Invitrogen) supplemented with collagenase I at 200 U ml À1 (Sigma). Cells were then rinsed, dissociated by pipetting up and down, and cultured in Dulbecco's Modified Eagle Medium (Invitrogen) supplemented with 20% heat-inactivated fetal calf serum (PAA laboratories, Etobicoke, Ontario, Canada) and 20 mM HEPES. After 1 week, serum concentration was decreased to 10%. All experiments with primary cells were performed after not more than three passages. All cell cultures had GFAP-positive cells that varied between 10 and 90% (data not shown).
Immunofluorescence analysis
Tissue sections were equilibrated to room temperature, then fixed in fresh acetone for 10 min and air dried. Slides were washed with phosphate-buffered saline three times for 5 min. Tissue sections were blocked with phosphatebuffered saline supplemented with 10% normal goat serum (Sigma) at 37 1C for 45 min. Rabbit anti-Cx43 (Sigma) at 1 mg ml À1 was applied to tumor sections for 45 min at 37 1C. The primary antibody was revealed by a goat anti-rabbit antibody conjugated to Alexa594 (1:1000; Invitrogen), and nuclei were stained with the Hoechst reagent. Each tumor sample was analysed in duplicate in two independent experiments. In each experiment, Cx43 expression was also quantified in healthy brain tissues and was used as a reference for 100% Cx43 fluorescence intensity. Slides were observed with a Bio-Rad (Mississauga, Ontario, Canada) MRC-1024 confocal microscope mounted on a Nikon Diaphot-TMD. Fluorescence intensity was quantified using the ImageJ 1.37v software (NIH, Bethesda, MD).
Primary cells were cultured on glass coverslips in 35-mm dishes until they reached subconfluency. Cells were then fixed in 4% paraformaldehyde, permeabilized with 0.2% Triton X-100 and incubated with a primary monoclonal antibody raised against Cx43 (1:800; Sigma) followed by an Alexa594-conjugated goat anti-mouse (1:1000; Invitrogen). Immunofluorescence experiments were carried out not later than the third cell passage.
Double-dye flow cytometry assay
The gap-junctional coupling was measured by flow cytometry as described previously. 22, 23 Cells plated in 12-well plates at 4 Â 10 5 cells per cm 2 were labeled with 3 mM calcein-AM (acetoxymethyl ester) or 5 mM DiI (Invitrogen) diluted in Opti-MEM medium (Invitrogen) for 30 min at 37 1C. Next, cells were washed twice with phosphate-buffered saline, and calcein-loaded cells were trypsinized and plated on top of the DiI-stained cells at a ratio of 1:10 (donors: recipients). After a 6-h incubation at 37 1C, cell mixtures were trypsinized and analyzed by flow cytometry. Fluorescence was measured with a Coulter EPICS XL-MCL flow cytometer and Expo32 software (Beckman Coulter, Brea, CA).
Plasmid construction
A lentiviral vector plasmid containing the TK gene fused to the green fluorescent protein (GFP) gene was constructed as follows: a 1.7 kbp BamHI GFP/TK insert isolated from the MFG-GFP/TK plasmid previously described was cloned in the pRRL lentiviral plasmid opened in BamHI.
23,24
Lentiviral vector production Recombinant lentiviruses were produced in subconfluent 293T cells as described previously. 24, 25 Cells seeded in a 10-cm tissue culture dish were transfected by the calcium phosphate procedure with 10 mg of pRRL-GFP/TK plasmid, 6.5 mg of pMDLG-pRRE encoding Gag-pol, 3.5 mg of pMD2.G encoding the vesicular stomatitis virus G envelope protein (VSV-G) and 2.5 mg of the pRSV-Rev plasmid encoding Rev. After 48 h, viral supernatants were harvested, clarified by centrifugation and kept frozen at À80 1C until use.
Bystander assay Primary glioma cell lines plated in 24-well plates (two wells for each cell line) were transduced by the GFP/TK lentiviral vector at low multiplicity of infection in the presence of polybrene at 8 mg ml À1 (Sigma). At 2 days after infection, cells expressing the TK gene were identified by immunofluorescence using an antibody raised against TK (1:1000 ; gracious gift from M Black, Washington State University, Pullman, WA). In the second well, infected cells were treated with 100 mM GCV, and 24 h later, cells were diluted to 1:10 and transferred into a 96-well plate. Cells were subsequently cultured in the presence of GCV for 5 to 6 days, until untreated cells reached confluency. Cell proliferation was then measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. MTT at a final concentration of 0.5 mg ml À1 was added to wells and the plates were incubated at 37 1C for 2 h. After medium removal, 150 ml of dimethyl sulfoxide was added and the plates were gently shaken for 10 min to dissolve the formazan blue crystals. The absorbance was then measured at 595 nm with a microplate reader (Tecan, Research Triangle Park, NC). 23 
Results

Connexin 43 expression in human glioblastoma
A conclusive picture of the status of Cx43 in glioblastoma can only be obtained by the analysis of a large number of clinical tumor samples. In this study, we report the study of the Cx43 status in a total of 74 glioblastoma samples. Experimental conditions for Cx43 staining were optimized with human healthy tissues from epileptic patients. As shown in Figure 1 , Cx43 expression was present as distinct large spots and streaks at regions of cell-cell contact, representative of gap-junctional plaques in astrocytes. 26 The Cx43 expression was detected by immunofluorescence in 77% of the tumors. About half of the samples expressed more than 25% of the levels observed in normal brain tissue obtained from epileptic patients, and among them, 12% displayed Cx43 staining as strong as the control. A weak Cx43 expression was detected in 29.7% of the samples. We were unable to detect Cx43 in only 23% of the tissues analysed ( Table 2 ). The localization of Cx43 was difficult to assess, but gap-junctional plaques could clearly be seen at the cell surface in a few samples. The presence of nuclei shown by DAPI staining indicated the presence of viable cells (Figure 2 ). Although we did not find any correlation between the presence of Cx43 expression and survival (data not shown), our results indicate that Cx43 expression is generally preserved in glioblastomas at predominantly lower levels as compared with normal tissue.
Connexin 43 localization and gap-junctional intercellular communication in primary glioblastoma cells Primary glioblastoma cell cultures were established to specifically assess the localization of Cx43 and the functionality of gap-junctional intercellular communication. Tumor samples obtained from nine patients undergoing surgical resections of their glioblastomas led to the successful generation of eight primary cell cultures. Cx43 was expressed and localized at the cell membrane, forming some large junctional plaques in the primary cells GBM1, GBM2 and GBM3 (Figures 3a-c) . On the other hand, the expression pattern of Cx43 was predominantly cytoplasmic with only few junctional plaques present at the cell surface of the primary cells GBM5, GBM6, GBM7 and GBM8 (Figures 3d-g ). In the GBM9 cell line, Cx43 was barely detected (Figure 3h) .
A double-dye flow cytometry assay was used to quantify gap-junctional intercellular communication in these primary glioblastoma cells. The calcein marker was able to diffuse from 10% calcein-AM loaded cells into 79.4, 89.8 and 81.1% DiI-labeled cells in the primary cells GBM1, GBM2 and GBM3, respectively. The dye transfer was inhibited in presence of a-glycyrrhetinic acid, a specific gap junction inhibitor (experiment performed with GBM2; data not shown). The primary cells that exhibited a predominant cytoplasmic Cx43 localization were less coupled but calcein could still diffuse to 17.2, 37.8, 44.9 and 23.8% DiI-labeled cells in the primary cells GBM5, GBM6, GBM7 and GBM8, respectively. Calcein could only diffuse in 3% DiI-labelled cells in GBM9 cells that have practically no Cx43 expression (Figure 4 ).
Bystander effect in glioblastoma primary cells
Nucleoside analogs that are used for treating solid tumors, alone 27 or in combination with gene transfer, 18 must rely on the gap junction-mediated BE for their success. In the TK/GCV strategy, the BE is the transfer of toxic GCV metabolites from TK-expressing cells to TKneighboring cells, and it is essential to the success of the TK/GCV gene therapy strategy. As the BE is mainly mediated via gap junctions, we have examined the extent of the BE in relation to gap-junctional intercellular communication in the primary glioblastoma cells. Cells infected with a lentiviral vector containing the TK gene were cultured in presence of GCV. The transduction efficiency of each cell line was measured in independent wells by immunofluorescence with an anti-TK antibody.
Using the same multiplicity of infection, the percentage of infected cells varied between 14 and 42%. Except for GBM9 cells that have a very low level of Cx43, all other primary cells had a transduction/cytotoxicity ratio lower than one, thereby indicating a bystander effect. The percentage of bystander cells killed were 10.7 (GBM2), 19.6 (GBM3) and 23.8 (GBM1) for the three cell lines that had Cx43 localized at the cell surface, and it was comprised between 14.7 and 27.1 for the cells that had a predominant Cx43 cytoplasmic localization ( Figure 5 ). Collectively, our data support the view that the extent of the BE is independent of the localization of Cx43 in glioblastomas.
Discussion
Downregulation and/or aberrant localization of connexins are common features in cancer cells. 28 In this study, we have analyzed the presence of Cx43 in glioblastoma samples as its status was not clearly defined in this tumor type. We found that Cx43 expression was present in 77% of the glioblastoma samples studied, and that its expression was often reduced as compared with normal tissue. A predominant cytoplasmic localization of Cx43 Several groups had previously investigated the status of Cx43 in glioblastomas with mixed results. Cx43 was detected at variable levels in practically all tested samples in three studies, [29] [30] [31] but in other reports there was a Gap junctions in human glioblastomas S Cottin et al marked decrease or absence of Cx43 in the majority of the samples analyzed. 10, 11, 13, 14 This lack of uniformity in results could be explained by the small numbers of examined specimens, and by the various techniques used to assess the level of Cx43 expression. In our study, we have analyzed 74 tumor samples by immunofluorescence and compared the level of Cx43 expression with the one found in normal tissue. This approach was preferred to western blot or northern blot of whole tumor tissues because the latter techniques would not differentiate between cancer cells and other Cx43-positive normal cells, like endothelial cells. 32 As the localization of Cx43 could not be easily evaluated in tissue samples, we have established eight glioblastoma primary cultures. Cx43 was barely detected in GBM9 cells and was localized at the cell surface in three primary cultures and predominantly in the cytoplasm in the remaining four. These results are in agreement with previous studies that reported an aberrant localization of Cx43 in glioblastoma cell lines 23, 29 and have confirmed the intracellular accumulation of Cx43 detected by immunohistochemistry in eight out of 16 high-grade epilepsy-associated tumors. 11 As shown by calcein transfer, gap-junctional intercellular communication was preserved when Cx43 was predominantly present in the cytoplasm, but it was significantly reduced as compared with the three primary cell lines that displayed Cx43 at the cell surface (Figure 4 ). In our previous study, a similar low level of gap-junctional intercellular communication was found in the glioblastoma cell line U251 but the two other cell lines, U87 and SKI-1 that had also a predominant cytoplasmic Cx43 localization, were strongly coupled. The gap-junctional intercellular communication intensity measured by dye transfer was then most likely due to a higher functionality of the few gap junctions present at the cell surface of U87 and SKI-1 cells. 23 The results reported here indicate that the cytoplasmic localization of Cx43 is a frequent event that is found in primary glioblastoma cells.
The TK/GCV strategy has been tested only once in a primary glioblastoma cell culture by transfection of a TKexpressing plasmid. 31 This primary cell culture expressed Cx43 and had functional gap junctions, although the intracellular localization of Cx43 was not assessed. In our study, the TK gene was delivered into cells with a lentiviral vector that has the ability to infect non-dividing cells, rendering it more suitable than the oncoretroviral vector to target slow-growing CD133 þ glioblastoma stem cells. 33 Except for the Cx43-negative GBM9 cells, all the other cell lines displayed a BE with values within the 10-30% range ( Figure 5 ). The BE intensities did not correlate with the localization of Cx43, and did not reflect the gap-junctional intercellular communication measured by calcein transfer. A difference in the gap junction permeability for calcein and phosphorylated GCV metabolites could explain these results. Also, the GCV sensitivity of each primary cell culture has a role in the BE; bystander cells that are more sensitive to GCV could still be killed with less GCV metabolites.
The BE values of the primary glioblastoma cells were low as compared with those obtained with multiplepassage cell lines, such as U251 and SKI-1. In our previous study, 60% SKI-1 bystander cells were killed with only 2% TK-expressing cells, and in the case of the less coupled U251 cell line, 30% bystander cells were still killed using the same ratio of TK-expressing cells. 23 In contrast, a lower percentage of TK-expressing cells and a higher GCV concentration (100 mM instead of 10 mM) was used in this study. We found that the level of TK expression was much lower in primary glioblastoma cells than in other cell lines using the same lentiviral vector or an oncoretroviral vector containing the same TK/GFP transgene (data not shown). Indeed, the direct fluorescence of TK/GFP could not be detected in primary glioblastoma cells despite its detection in cell lines like SKI-1, U251 and U87. We could only detect the expression of the fusion protein in primary cells with an anti-TK antibody that is more sensitive than the direct GFP fluorescence of the fusion protein. The finding of such a limited TK expression in glioblastoma cells is highly relevant in the context of TK/GCV clinical trials, and could in part explain some of the poor results obtained by oncoretroviral-mediated gene delivery. 34 This is the first study that has examined the presence of Cx43 in a large number of glioblastoma samples. The overall conclusion of our study is that Cx43 expression and gap-junctional intercellular communication are maintained in the majority of glioblastomas. Thus, we show that glioblastoma is a heterogenous disease as regards Cx43 expression with presentations in which Cx43 expression is unaltered, reduced, or totally lost. Furthermore, when present, Cx43 is often found intracellularly. The existence of gap-junctional intercellular communication in these tumors may have important clinical implications for the design of anti-cancer cytotoxic therapies that rely on the gap junction-mediated BE for their success. 18, 27 
